P1.12A.09 A Phase 1b Study of the MER Tyrosine Kinase Inhibitor, MRX-2843, in Combination with Osimertinib in Advanced EGFR Mutant Non-Small Cell Lung Cancer

Saved in:
Bibliographic Details
Published inJournal of thoracic oncology Vol. 19; no. 10; p. S196
Main Authors Steuer, C., Carlisle, J., Leal, T., Ardeshir, F., Holmes, M., Schneider, F., Chen, Z., Switchenko, J., Ross, J., Selvagi, G., Owonikoko, T., ramalingam, s.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.10.2024
Online AccessGet full text

Cover

More Information
ISSN:1556-0864
DOI:10.1016/j.jtho.2024.09.355